Blood Glucose Monitoring Market in Global Industry: Demands, Insights, Research and Forecast 2020-2027
The blood glucose monitoring market is one of the rapidly
growing markets across the world owing to huge growth in urbanization leading
to the increased incidence of obesity, unhealthy diet, and physical
inactiveness, which has increased the diabetic population around the globe.
Regular monitoring of glucose level is important to avoid further
complications.
The global blood
glucose monitoring market is expected to grow at a CAGR of 7.1% during
forecasted period 2017-2023.Furthermore, invention of new technology,
increasing awareness, investment in research and development have boosted the
blood glucose monitoring market globally. However, high cost associated with
monitoring and diagnosis of disease may restrain the market growth.
Key Players
Some of key the players in the market are Abbott Laboratories (U.S.), Arkay, Inc. (U.S.), Bayer Healthcare AG (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Goldsite Diagnostics Inc., GlySure Ltd (U.K), Sphere Medical Holding plc. (U.K), Dexcom, Inc. (U.S.), and LifeScan, Inc. (U.S.)
.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/557
Segmentation
Global blood glucose monitoring devices market is segmented
on the basis of product type, application, and end user. On the basis of the
product type, it is segmented into invasive glucose monitoring devices,
continuous glucose monitoring devices (CGM), flash glucose monitoring devices,
and others. On the basis of the application, it is segmented into type 1
diabetes, type 2 diabetes, and others. On the basis of the end user, it is
segmented into diagnostic centers, hospitals, clinics, research centers, and
home care diagnostics.
Regional Analysis
Geographically, global blood glucose monitoring market is
segmented into America, Europe, Asia Pacific and the Middle East & Africa.
The Americas commands the largest blood glucose monitoring
market due to the presence of a well-developed healthcare sector and large
patient population. Americas dominate the global blood glucose monitoring
market owing to high healthcare spending, increasing population, increased
research & development activities and the concentration of major companies
have fuelled the growth of the market in this region.
Europe holds the second position in the global blood glucose
monitoring market owing to the government support for research &
development and availability of funds for research. According to WHO, Globally,
around 3.4 million people died annually owing to high blood glucose and almost
80% of these deaths occur in lower and middle income countries, and this
statistics is coupled with the fact that almost 50% were people aged under 70
years.
Asia Pacific is the fastest growing blood glucose monitoring
market owing to the presence of rapidly developing healthcare technology, huge
patient population, high healthcare expenditure, and increase in prevalence of
nerve injuries or disorder related to nerve. Moreover, increasing demand for
new treatment methods in countries like India and China are likely to emerge as
the fastest growing market across the globe.
On the other hand, in the Middle East and Africa has the
lowest market for blood glucose monitoring due to lack of technical knowledge
and poor medical facilities.
Browse Detailed TOC
with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/blood-glucose-monitoring-market-557
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to
unravel the complexity of various industries through our Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR
team have supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Comments
Post a Comment